Market Overview

AnaptysBio (NASDAQ: ANAB)

68.53 -1.96 (-2.78%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/21/18JP MorganInitiates Coverage OnOverweight115.0
9/27/18Credit SuisseMaintainsOutperform147.0
9/14/18Stifel NicolausReinstatesBuy127.0
8/28/18Cantor FitzgeraldInitiates Coverage OnOverweight124.0
8/15/18JMP SecuritiesMaintainsMarket Outperform153.0
7/19/18Credit SuisseInitiates Coverage OnOutperform104.0
4/04/18RBC CapitalDowngradesSector Perform
3/27/18Stifel NicolausMaintainsBuy152.0
3/06/18Stifel NicolausMaintainsBuy139.0
2/20/18WedbushMaintainsOutperform151.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter